Makerere University
mak.ac.ugTotal trials
141
Active
13
Phase 3
25
Total enrollment
235,779
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Single dose liposomal Amphotericin and Fluconazole | — | — | — | — | — | 1 | |
| Fluconazole | — | — | — | — | — | 1 | |
| Doxycycline | — | — | — | — | — | 2 | |
| CAd3 | — | — | — | — | — | 1 | |
| ChAdox1 | — | — | — | — | — | 1 | |
| rVSV-SUDV | — | — | — | — | — | 1 |
Next readouts
- 2026-12-20
- 2027-06
- 2027-09
Top conditions
- HIV11
- HIV Infections10
- Malaria8
- HIV/AIDS6
- Tuberculosis6
- Covid193
- HIV-1-infection3
- PrEP3
Frequently asked questions about Makerere University
- How many clinical trials does Makerere University have on ClinicalTrials.gov?
- Makerere University is listed as the lead sponsor on 141 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Makerere University's trials are in Phase 3?
- 25 of Makerere University's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does Makerere University focus on?
- Makerere University's most-studied conditions on ClinicalTrials.gov are HIV, HIV Infections, Malaria, HIV/AIDS, Tuberculosis.
- When are Makerere University's next clinical trial readouts?
- Makerere University has 3 upcoming primary-completion readouts tracked here; the soonest is “Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline”, expected around 2026-12-20.